PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.82%
Negative revenue growth while 1113.HK stands at 122.89%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
58.31%
Gross profit growth under 50% of 1113.HK's 193.79%. Michael Burry would be concerned about a severe competitive disadvantage.
No Data
No Data available this quarter, please select a different quarter.
17.02%
Operating income growth under 50% of 1113.HK's 186.30%. Michael Burry would be concerned about deeper cost or sales issues.
-145.72%
Negative net income growth while 1113.HK stands at 48.37%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-144.83%
Negative EPS growth while 1113.HK is at 48.04%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-144.83%
Negative diluted EPS growth while 1113.HK is at 48.04%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-111.34%
Negative OCF growth while 1113.HK is at 1967.06%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-133.64%
Negative FCF growth while 1113.HK is at 1925.35%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-92.97%
Negative 10Y revenue/share CAGR while 1113.HK stands at 312.05%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
22775.59%
5Y revenue/share CAGR above 1.5x 1113.HK's 312.05%. David Dodd would look for consistent product or market expansions fueling outperformance.
2990.65%
3Y revenue/share CAGR above 1.5x 1113.HK's 312.05%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-222.25%
Negative 10Y OCF/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-149.48%
Negative 5Y OCF/share CAGR while 1113.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-263.02%
Negative 3Y OCF/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-517.17%
Negative 10Y net income/share CAGR while 1113.HK is at 19.83%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-3602.95%
Negative 5Y net income/share CAGR while 1113.HK is 19.83%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-13520.87%
Negative 3Y CAGR while 1113.HK is 19.83%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
210.52%
Below 50% of 1113.HK's 1188.47%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
10.06%
Below 50% of 1113.HK's 1188.47%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 1113.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-34.15%
Firm’s AR is declining while 1113.HK shows 35.28%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
356.23%
We show growth while 1113.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-27.14%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-21.25%
We have a declining book value while 1113.HK shows 0.63%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-83.31%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
531.86%
SG&A growth well above 1113.HK's 366.36%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.